Learn more at LeadIQ.com

Insights

Recent Investment Influx iTeos Therapeutics has attracted significant investment recently, with a total funding amount surpassing $120 million. This influx of capital indicates strong investor confidence in the company's potential for growth and success.

High-Profile Appointments The appointment of David Feltquate as the Chief Medical Officer showcases iTeos Therapeutics' commitment to strengthening its leadership team with seasoned professionals. Leveraging such high-profile executives can enhance the company's credibility and open doors to strategic partnerships.

Strategic Acquisitions Several prominent investment firms like Acadian Asset Management, Aristides Capital LLC, and Quest Partners LLC have made substantial investments in iTeos Therapeutics. This signals a vote of confidence from industry experts, presenting an opportunity to explore collaborations or partnerships with these firms.

Competitive Landscape Analysis By examining similar companies in the biotechnology research sector, such as IO Biotech and Harpoon Therapeutics, it becomes evident where iTeos Therapeutics stands in terms of employee size, revenue, and market positioning. This analysis can provide valuable insights for tailoring sales strategies to outperform competitors.

Diverse Funding Sources With a diverse range of financing sources, including investments from firms like Adage Capital Partners and AJOVista LLC, iTeos Therapeutics demonstrates resilience and adaptability in raising capital. Exploring collaborations or co-investment opportunities with these funding partners could further fuel the company's growth trajectory.

Similar companies to iTeos Therapeutics

iTeos Therapeutics Tech Stack

iTeos Therapeutics uses 8 technology products and services including Google Analytics, Drupal, SAP, and more. Explore iTeos Therapeutics's tech stack below.

Google Analytics
Analytics
Drupal
Content Management System
SAP
Customer Relationship Management
Microsoft 365
Email
Hammer.js
Javascript Libraries
Open Graph
Miscellaneous
Yoast SEO
Search Engines
Cloudflare Bot Management
Security

Media & News

iTeos Therapeutics's Email Address Formats

iTeos Therapeutics uses at least 1 format(s):

iTeos Therapeutics Email Formats	Example	Percentage
First.Last@iteostherapeutics.com	John.Doe@iteostherapeutics.com	95%
Last@iteostherapeutics.com	Doe@iteostherapeutics.com	3%
First.Middle@iteostherapeutics.com	John.Michael@iteostherapeutics.com	1%
First.MiddleLast@iteostherapeutics.com	John.MichaelDoe@iteostherapeutics.com	1%

Frequently Asked Questions

Where is iTeos Therapeutics's headquarters located?

iTeos Therapeutics's main headquarters is located at 139 Main Street Cambridge, Massachusetts 02142 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is iTeos Therapeutics's phone number?

You can contact iTeos Therapeutics's main corporate office by phone at

+32-71-91-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is iTeos Therapeutics's stock symbol?

iTeos Therapeutics is a publicly traded company; the company's stock symbol is ITOS.

What is iTeos Therapeutics's official website and social media links?

iTeos Therapeutics's official website is iteostherapeutics.com and has social profiles on LinkedIn.

How much revenue does iTeos Therapeutics generate?

As of September 2024, iTeos Therapeutics's annual revenue reached $35M.

What is iTeos Therapeutics's SIC code NAICS code?

iTeos Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does iTeos Therapeutics have currently?

As of September 2024, iTeos Therapeutics has approximately 184 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer (interim): J. K.Chief Scientific Officer: Y. M.Chief Information Security Officer: C. J.. Explore iTeos Therapeutics's employee directory with LeadIQ.

What industry does iTeos Therapeutics belong to?

iTeos Therapeutics operates in the Biotechnology Research industry.

What technology does iTeos Therapeutics use?

iTeos Therapeutics's tech stack includes Google AnalyticsDrupalSAPMicrosoft 365Hammer.jsOpen GraphYoast SEOCloudflare Bot Management.

What is iTeos Therapeutics's email format?

iTeos Therapeutics's email format typically follows the pattern of . Find more iTeos Therapeutics email formats with LeadIQ.

How much funding has iTeos Therapeutics raised to date?

As of September 2024, iTeos Therapeutics has raised $120M in funding. The last funding round occurred on May 10, 2024 for $120M.

When was iTeos Therapeutics founded?

iTeos Therapeutics was founded in 2011.

iTeos Therapeutics

iTeos Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.

Company Overview

Headquarters: 139 Main Street Cambridge, Massachusetts 02142 US
Phone number: ✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+32-71-91-9****
Website: iteostherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ITOS
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2011
Employees: 51-200

Media & News

Funding & Financials

$120M
iTeos Therapeutics has raised a total of $120M of funding over 9 rounds. Their latest funding round was raised on May 10, 2024 in the amount of $120M.
$10M$50M
iTeos Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$120M
iTeos Therapeutics has raised a total of $120M of funding over 9 rounds. Their latest funding round was raised on May 10, 2024 in the amount of $120M.
$10M$50M
iTeos Therapeutics's revenue is in the range of $10M$50M

Company Leadership

J. K.
Chief Medical Officer (interim)
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Y. M.
Chief Scientific Officer
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. J.
Chief Information Security Officer
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Chief Operating Officer
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. K.
Chief Accountant
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

S. A.
Svp, Clinical Development
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. D.
Senior Director, Head Of Biometrics
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. R.
Vp Project Head
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. M.
Vp, Head Of Pharmacovigilance
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. S. G.
Vp, Global Head Of Cmc
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for iTeos Therapeutics and Millions of Other Companies
Sign up for full access to iTeos Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.